Fundraising Fox
/Companies
Sign in

Vahaticor

Santa Clara, US · Founded 2021 · 3 known investors

Find your way into Vahaticor

Sign up to see every warm intro you have to Vahaticor

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vahaticor team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.

HardwareHealthtechMedical Devices

Founders & leadership

Vahaticor was founded in 2021 by Marwan Berrada.

MBMarwan Berrada
Marwan BerradaFounder and ChairmanMarwan Berrada is a biomedical engineer and business development professional with over 20 years of experience in medical device product development and commercialization, with expertise in percutaneous therapies including electrophysiology, structural heart, cardiovascular, and endovascular devices; he holds multiple patents and FDA clearances for medical devices.
HRHarry Rowland
Harry RowlandCEOHarry D. Rowland recently served as co-founder and CEO of Endotronix, where he led development of the Cordella Heart Failure System and raised over $150M in financing before the company's acquisition by Edwards Lifesciences in 2024. He holds a PhD in mechanical engineering from Georgia Institute of Technology and a BS in mechanical engineering and MA in economics from UC Santa Barbara.
KVKevin Van Bladel
Kevin Van BladelChief Technology Officer
MNMark Niggli
Mark NiggliChief Commercial Officer
MBMarwan Berrada-Sounni
Marwan Berrada-SounniBoard of Directors Member and Co-FounderExecutive Officer, Director at Advanced Nanotherapies

Board

BRBrian R. Smith
Brian R. SmithBoard of DirectorsManaging Director at S3 Ventures
DS
Daniel SheehanBoard director
JC
Jerrett CreedBoard director
BS
Bruce SamuelsBoard director

Investors · 3

S3 Ventures✓ confirmed by VahaticorAustin · $500K – $15M

How we know: S3 Ventures's portfolio page · the company's own site · a partner's Signal profile · funding news · marketscreener.com · Not right? Tell us

Also in the syndicate · 1

Intuitive Surgical, Inc.

Reported raises · per SEC filings

Form D private placements

$21.2M disclosed across 1 round · 2025

▶$21.2MraisedDec 2025 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian R. SmithDirector
  • Marwan Berrada-SounniExecutive Officer, Director
  • Daniel SheehanDirector
  • Jerrett CreedDirector
  • Bruce SamuelsDirector
Offering amount
$32.4M
Amount sold
$21.2M
First sale
Nov 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Vahaticor went on to found or lead other companies.

Brian R. SmithDirectorFounded Crossroads SystemsTerri BurkeBoard ObserverFounded Protaryx MedicalMarwan Berrada-SounniExecutive Officer, DirectorFounded Advanced NanotherapiesHarry RowlandCEOFounded Endotronix

Frequently asked questions

What does Vahaticor do?
VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.
Who founded Vahaticor?
Vahaticor was founded by Marwan Berrada in 2021.
Who are Vahaticor's investors?
Vahaticor's investors include Intuitive Ventures, S3 Ventures.
How much funding has Vahaticor raised?
Vahaticor has disclosed $21.2M raised across 1 round.
Where is Vahaticor headquartered?
Vahaticor is headquartered in Santa Clara, US.